PreventiveNCIt concept

https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1381
2024
false
false
false
France
public health guidelines
preventive immunization/medication
Vaccination
cholera vaccines
comoros
vaccination
cholera
Preventive
cholera vaccination
Cholera
mayotte
residence characteristics
vaccination

---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-du-reseau-francophone-de-litteratie-en-sante-nicolas-giraudeau
2024
France
audiovisual aids
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Another Form of Birth Control was not Used
Medical Examination
BRAF Mutation Analysis Was Not Performed
Unemployed
No Response to Intervention for Kawasaki Disease
Preventive
Use of Smokeless Tobacco at Time of Diagnosis Negative
Family History of Stomach Cancer Absent
No Known History of Illicit Drug Use
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
RET Rearrangement Analysis Was Not Performed
Negation
Adjuvant Post-operative Chemotherapy Was Not Administered
KRAS Mutation Analysis Was Not Performed
Chemical/Occupational Exposure Absent
IV Anesthesia was not Administered
health literacy
Caffeine Not Routinely Consumed
Literacy
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
IDH Family Wildtype
Additional Molecular Studies Were Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
Not Lost to Follow-Up
Documentation Absent
NRAS Mutation Analysis Was Not Performed
Scheduled
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Radiation Therapy Was Not Administered
EGFR Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Any Metastatic Diagnosis Absent
No History of Neonatal Complication
PTEN Mutation Analysis Was Not Performed
NF1 Mutation Analysis Was Not Performed
Regional Anesthesia was not Administered
Paraneoplastic Syndrome is Not Present
No History of Myopathy
ATRX Mutation Analysis Was Not Performed
Other Preoperative IV Medications were not Administered
Fluorescence In Situ Hybridization Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
Schedule
EGFR Gene Amplification Negative
ERBB2 Mutation Analysis Was Not Performed
No History of Congenital Heart Disease
Adjuvant I-131 Therapy Negative
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
BRAF Rearrangement Analysis Was Not Performed
Tumor Progression Absent After Initial Treatment
TP53 Mutation Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
First Degree Family History Cancer Negative
No Known History of Alcohol Use
EGFR Amplification Analysis Was Not Performed
Additional Immunohistochemistry Was Not Performed
First Degree Family History of Primary Brain Tumor Negative
Radiation Therapy Not Received
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
medical computer science
No History of Gestational Complication
digitalis, nos
New Tumor Event After Initial Treatment Absent
ATRX Gene Mutation Negative
Evidence of Disease Absent after Completion of Therapy
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Local Anesthesia Agents were not Administered
NON Mouse
Chemotherapy Not Received
PTEN Gene Mutation Negative
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
digitalis
Nitric Oxide
Medication Not Taken
Hypertension Absent
Lymph Node Dissection Was Not Performed
No History of Non-Cardiac Surgery
History of Medical Treatment Absent
Patient was Not Previously Evaluated for Current Chief Complaint
IDH Family Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
program evaluation
KIT Mutation Analysis Was Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Radiation History Negative
Preoperative IV Antacids were not Administered
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Additional Surgery for New Tumor Event Absent
Preoperative IV Antiemetics were not Administered
Physician Diagnosed Diabetes Absent
Has No Sibling
Digitalis
Routine Cytogenetics Were not Completed
Neither
Nitric Oxide Measurement
Regulatory Action
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No History of Rheumatic Fever
Preoperative IV Sedation was Not Administered
Therapeutic Ionizing Radiation to Head History Absent
MET Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Neither Case or Control Status
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Preoperative IV Opiates were not Administered
Norway
Intercurrent Illness is Absent at Onset of Chief Complaint
History of Colorectal Cancer Negative
Chief Complaint Not Caused by Trauma
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Chief Complaint was Not Witnessed
10q23/PTEN Locus Deletion Analysis Was Not Performed
No History of Kawasaki Disease
New Disease is not Multifocal
PDGFRA Mutation Analysis Was Not Performed
non-communicating
MGMT Promoter Methylation Testing Was Not Performed
Intervention Not Given for Kawasaki Disease
Tumor Reoccurrence Absent After Initial Treatment
ALK Rearrangement Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
Cancer History Absent
Patient was not Postmenopausal with no Prior Oophorectomy
1p/19q Deletion Analysis Was Not Performed

---
https://www.insee.fr/fr/statistiques/8186056?sommaire=8186084
2024
France
journal article
health behavior
Impact
Output
IPSS-R Risk Category High
Arginine/Omega-3 Fatty Acids/Nucleotides Oral Supplement
IPSS Risk Category High
senegalese
High-Frequency Microsatellite Instability
Health Behavior
senegal
Value Above Reference Range
preventive medicine
behavior, nos
Topical Dosage Form
High Mitosis-Karyorrhexis Index
Topical Route of Administration
Preventive
internet
Backflow
High Level

---
https://rmlg.uliege.be/article/3913
2024
France
journal article
caregivers
Approach
Device System
Version
has provider
health
Systemic Immunotherapy
preventive medicine
delivery of health care
Preventive
Drug Delivery System
Drug Delivery System Category

---
https://www.has-sante.fr/jcms/p_3536535/fr/traitement-preventif-post-exposition-au-vih
2024
France
practice guideline
Therapy Object
Biomaterial Treatment
Post-Exposure prophylaxis
No Treatment for Diabetes
Exposure
Preventive Intervention
Treatment Epoch
preventive treatment, nos
Treatment
Human Immunodeficiency Virus
Preventive
Under No Medication
human immunodeficiency virus, nos
GDC Treatment Frequency Terminology
HIV
Preventative Therapy Clinical Trial Setting
Exhibition
effects of exposure to external cause, nos
During Treatment
Exposure Domain
Treat
Treatment Study
On Treatment

---
https://www.who.int/fr/publications/i/item/9789240086272
2024
Switzerland
technical report
Treatment Epoch
Dental Base
Therapy Object
sulfadoxine
Baseline
pregnancy, nos
Pregnant
malaria
During Treatment
malaria
Field
Preventive Intervention
In the Field
Knowledge Field
Quartan Malaria
malaria, nos
Plasmodium Measurement
Base of the Prostate
Data Field
Core Device
Treatment Study
Nucleotide
base, nos
preventive treatment, nos
No Treatment for Diabetes
Guide Device
pyrimethamine with sulfadoxine
Vivax Malaria
pyrimethamine
Pyrimethamine-Sulfadoxine
Pregnancy
Biomaterial Treatment
Preventative Therapy Clinical Trial Setting
GDC Treatment Frequency Terminology
Preventive
Treat
On Treatment
fanasil, pyrimethamine drug combination
Core Specimen
source guides
Electronic System Deployment
Treatment
pregnancy
Malaria Pathway
Baseline Epoch
Under No Medication

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/traitement-intravesical-du-cancer-de-la-vessie.html
2024
Canada
technical report
review of literature
guideline
weights and measures
musculoskeletal rotation, nos
Preventive
Bacillus Calmette-Guerin Antigen
measures
Childhood Bladder Carcinoma
patients
preventive treatment, nos
Epidermolytic Ichthyosis
Patient Reported Outcome Measures
has patient
malignant neoplasm of bladder
BCG
KRT10 wt Allele
Cancer Therapeutic Procedure
BCG
Intravesical
Intravesical Route of Administration
rotation
BCG Vaccine
BCG
urinary bladder cavity
People
urinary bladder cancer
neoplasm, malignant
mycobacterium bovis
persons
Clinical Outcomes Assessment Context of Use
Patient
immunocompromised host
urinary bladder neoplasms
Bladder Cancer Pathway

---
http://beh.santepubliquefrance.fr/beh/2024/14/2024_14_2.html
2024
France
journal article
weights and measures
attention
Instruction
france
pandemics
teaching
Preventive
Patient Reported Outcome Measures
Other Chief Complaint
Other Family History of Heart Disease
Apply
Comparison
Apply
School Teachers
measures
COVID-19 Infection
french
Cohort Study
COVID-19
Pandemic Disorder
Applicator
CHFR Gene

---
https://www.has-sante.fr/jcms/p_3536524/fr/traitement-preventif-pre-exposition-de-l-infection-par-le-vih
2024
France
practice guideline
hiv infections
Treatment Epoch
During Treatment
Preventive Intervention
No Treatment for Diabetes
Treat
Exposure Domain
Preventive
PITRM1 wt Allele
GDC Treatment Frequency Terminology
Under No Medication
Biomaterial Treatment
human immunodeficiency virus infection, nos
preventive treatment, nos
Treatment
effects of exposure to external cause, nos
Treatment Study
Therapy Object
Exposure
HIV Infection
infection control
Grassland
On Treatment
Exhibition
Preventative Therapy Clinical Trial Setting

---
https://sante.gouv.fr/actualites/actualites-du-ministere/article/contre-la-bronchiolite-un-traitement-preventif-et-des-gestes-simples
2023
France
popular works
Treat
bronchiolitis
Treatment Study
Therapy Object
On Treatment
Bronchiolitis
During Treatment
bronchiolitis, nos
GDC Treatment Frequency Terminology
Biomaterial Treatment
gestures
preventive treatment, nos
Simple Endometrial Hyperplasia
Treatment Epoch
Preventative Therapy Clinical Trial Setting
Preventive Intervention
Treatment
Preventive
No Treatment for Diabetes

---